Search research articles
Contact Us
Filters
Showing results (121-130 of 167) with videos related to
Page
of 17
Sort By:
European Urology Oncology
|
July 19, 2022
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Géraldine Pignot, Antoine Thiery-Vuillemin, Laurence Albigès, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial
François-Clément Bidard, Nicolas Kiavue, William Jacot, et al.
Clinical Genitourinary Cancer
|
August 17, 2022
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Elie Rassy, Cécile Dalban, Emeline Colomba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
Nicholas Turner, Cristina Saura, Philippe Aftimos, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators
Jihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Clinical Genitourinary Cancer
|
November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population
Andrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
World Journal of Urology
|
January 3, 2025
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma
Geraldine Pignot, Gaelle Margue, Pierre Bigot, et al.
Scientific Reports
|
August 18, 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
Alexandre de Moura, Perrine Vuagnat, Benjamin Renouf, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
The Journal of Clinical Investigation
|
January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 167) with videos related to
Sort By:
Page
of 17
European Urology Oncology
|
July 19, 2022
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Géraldine Pignot, Antoine Thiery-Vuillemin, Laurence Albigès, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial
François-Clément Bidard, Nicolas Kiavue, William Jacot, et al.
Clinical Genitourinary Cancer
|
August 17, 2022
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Elie Rassy, Cécile Dalban, Emeline Colomba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
Nicholas Turner, Cristina Saura, Philippe Aftimos, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 31, 2017
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators
Jihane Boustani, Aurélie Bertaut, Matthew D Galsky, et al.
Clinical Genitourinary Cancer
|
November 22, 2017
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population
Andrea Necchi, Gregory R Pond, Sumanta K Pal, et al.
World Journal of Urology
|
January 3, 2025
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma
Geraldine Pignot, Gaelle Margue, Pierre Bigot, et al.
Scientific Reports
|
August 18, 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
Alexandre de Moura, Perrine Vuagnat, Benjamin Renouf, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
The Journal of Clinical Investigation
|
January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Page
of 17